Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2021; 10(02): 120-126
DOI: 10.1055/s-0041-1731903
Original Article: Lung Cancer

Outcomes of Palliative Radiotherapy in Metastatic Epidural Spinal Cord Compression in Lung Cancer—A Prospective Observational Study from Tata Memorial Hospital

Anil Tibdewal
1   Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Alisha Sharma
1   Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Lavanya Gurram
1   Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Naveen Mummudi
1   Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, Maharashtra, India
,
Jaiprakash Agarwal
1   Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, Maharashtra, India
› Author Affiliations Funding The study was funded by an intramural grant of Tata Memorial Centre, Mumbai (grant number - 3583).
› Further Information
   Permissions and Reprints

Abstract

Background Metastatic epidural spinal cord compression (MESCC) secondary to lung cancer (LC) is a debilitating complication associated with poor prognosis and is commonly treated with radiotherapy (RT). There is no consensus for RT dose fractionation in spinal cord compression.

Methods Forty consecutive patients of LC with radiological evidence of MESCC treated with palliative RT were evaluated for functional outcomes (pain, ambulation, and sphincter function) at 2-, 4-, and 24-week post RT completion. Pain assessment was done using visual analogue scale (VAS) and response was categorized according to international consensus criteria, ambulation status (AS) using Tomita’s scale, and sphincter function by the presence or absence of a catheter. Overall survival (OS) was assessed using Kaplan-Meier method and compared using log-rank test. Impact of potential prognostic factors on survival was also analyzed and p-value ≤0.05 was considered significant.

Results Sixteen, 22, and two patients received 8 Gy single fraction (SF), 20 Gy in five fractions (20/5), and 30 Gy in 10 fractions (30/10), respectively. At 2 weeks, overall response (OR) rates of pain, ambulation, and sphincter control were 73, 81, and 81%, respectively. At 4 and 24 weeks, 93.7, 84.3, 87.5% and 88, 94, 76.5% had OR, respectively. Median OS was 4 months. Six- and 12-months OS was 50 and 37.5%. Nonsignificant difference in OS was seen between SF and 20/5 fractions (median 2.2 vs. 7.1 months, p = 0.39). Age ≤50 years was the only significant factor (p <0.05) in univariate analysis for OS.

Conclusion Radiotherapy provided equivalent pain control, ambulation, and sphincter function compared with reported literature in MESCC. Nonsignificant difference in OS exists between SF and multifraction RT regimens.

Keywords

cord compression - radiotherapy - lung cancer - ambulation


Publication History

Article published online:
04 September 2021

© 2021. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Loblaw DA, Mitera G, Ford M, Laperriere NJA. A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. Int J Radiat Oncol Biol Phys 2012; 84 (02) 312-317
    CrossrefPubMedGoogle Scholar
  • 2 Byrne TN, Byrne TN. Spinal cord compression from epidural metastases. N Engl J Med 1992; 327 (09) 614-619
    CrossrefPubMedGoogle Scholar
  • 3 Rades D, Douglas S, Veninga T. et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 2010; 116 (15) 3670-3673
    CrossrefPubMedGoogle Scholar
  • 4 Ryu S, Maranzano E, Schild SE. et al. International survey of the treatment of metastatic spinal cord compression. J Radiosurg SBRT 2015; 3 (03) 237-245
    PubMedGoogle Scholar
  • 5 Patchell RA, Tibbs PA, Regine WF. et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005; 366 (9486) 643-648
    CrossrefPubMedGoogle Scholar
  • 6 Klimo Jr P, Thompson CJ, Kestle JRW, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-oncol 2005; 7 (01) 64-76
    CrossrefPubMedGoogle Scholar
  • 7 Maranzano E, Bellavita R, Rossi R. et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005; 23 (15) 3358-3365
    CrossrefPubMedGoogle Scholar
  • 8 Maranzano E, Trippa F, Casale M. et al. 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009; 93 (02) 174-179
    CrossrefPubMedGoogle Scholar
  • 9 Rades D, Šegedin B, Conde-Moreno AJ. et al. Radiotherapy with 4 Gy × 5 versus 3 Gy × 10 for metastatic epidural spinal cord compression: final results of the SCORE-2 Trial (ARO 2009/01). J Clin Oncol 2016; 34 (06) 597-602
    CrossrefPubMedGoogle Scholar
  • 10 Thirion P, O’Sullivan L, Clayton-Lea A. et al. ICORG 05–03: prospective randomized non-inferiority phase 3 trial comparing two radiation schedules in malignant spinal cord compression not proceeding with surgical decompression. Int J Radiat Oncol 2014; 90 (05) 1263-1264
    CrossrefGoogle Scholar
  • 11 Lee KA, Dunne M, Small C. et al. (ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis. Acta Oncol 2018; 57 (07) 965-972
    CrossrefPubMedGoogle Scholar
  • 12 Hoskin PJ, Hopkins K, Misra V. et al. Effect of single-fraction vs multifraction radiotherapy on ambulatory status among patients with spinal canal compression from metastatic cancer: the SCORAD randomized clinical trial. JAMA 2019; 322 (21) 2084-2094
    CrossrefPubMedGoogle Scholar
  • 13 Chow E, Hoskin P, Mitera G. et al. International Bone Metastases Consensus Working Party. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 2012; 82 (05) 1730-1737
    CrossrefPubMedGoogle Scholar
  • 14 Tomita T, Galicich JH, Sundaresan N. Radiation therapy for spinal epidural metastases with complete block. Acta Radiol Oncol 1983; 22 (02) 135-143
    CrossrefPubMedGoogle Scholar
  • 15 Donovan EK, Sienna J, Mitera G, Kumar-Tyagi N, Parpia S, Swaminath A. Single versus multifraction radiotherapy for spinal cord compression: a systematic review and meta-analysis. Radiother Oncol 2019; 134: 55-66
    CrossrefPubMedGoogle Scholar
  • 16 Solomon BJ, Mok T, Kim D-W. et al PROFILE 1014 Investigators. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 2014; 371 (23) 2167-2177
    CrossrefPubMedGoogle Scholar
  • 17 Mok TS, Wu Y-L, Thongprasert S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361 (10) 947-957
    CrossrefPubMedGoogle Scholar
  • 18 Rades D, Fehlauer F, Schulte R. et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006; 24 (21) 3388-3393
    CrossrefPubMedGoogle Scholar
  • 19 Rades D, Panzner A, Rudat V, Karstens JH, Schild SE. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis. Strahlenther Onkol 2011; 187 (11) 729-735
    CrossrefPubMedGoogle Scholar
  • 20 Rades D, Douglas S, Veninga T, Schild SE. A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer 2012; 12: 302
    CrossrefPubMedGoogle Scholar
  • 21 Silva GT, Bergmann A, Thuler LCS. Incidence, associated factors, and survival in metastatic spinal cord compression secondary to lung cancer. Spine J 2015; 15 (06) 1263-1269
    CrossrefPubMedGoogle Scholar